ColorDx® CCT HD®
High-Precision Diagnostic Color Vision Testing
Color vision and contrast sensitivity are important functions of the visual system, which may be affected by many diseases, disorders and common drugs and substances.
Understanding if and how much visual function is affected may assist clinical decision making and augment conversations with your patients.
DR, glaucoma, AMD, MS
Other disorders of the retina or optic nerve
Pre and post cataract surgery
Vocational, avocational, and scholastic color
Track the effect of supplements over time2ColorDx is not cleared for the specific diagnosis of any condition
Detect subtle changes missed by books, plates, and other color vision tests
Compare structure & function, especially when subjective SAP does not correlate with OCT
Inform patients about the risks, consequences and hazards related to deficiencies in their cone and achromatic contrast sensitivity
FDA Listed | CPT Code 92283
Available in Canada
ColorDx CCT HD
The new gold standard in diagnostic color vision testing
Assess visual function beyond high-contrast acuity
Developed in collaboration with the U.S. Air Force School of Aerospace Medicine OBVA (Operational Based Vision Assessment) laboratory under CRADA, CCT HD expands on the strengths of the original USAF cone-isolation contrast test (Rabin CCT) and is built from the ground up with entirely new architecture.
Cone-isolation contrast sensitivity methodology
Expanded low-contrast range testing
“Landolt C” based test strategies
Simple to use 4-button response pad
Robust Bayesian threshold with standard error
Konan custom-calibrated IPS matte display technology
Rapid, intuitive, staged calibration
High fidelity cone-contrast granularity
Expansive illustrated reporting
Auto trends analysis
Contrast Sensitivity (achromatic) with auto AUC calculation
…and much more
Eye Care Beyond Black and White
Color Vision Changes in Macular Disease
Andrew Browne, MD PhD
Clinical Assistant Professor, Ophthalmology
Vitreoretinal Diseases and Surgery
Gavin Herbert Eye Institute, UC Irvine Health
Visual acuity measurement is the gold standard for evaluating visual function. However, contrast and color vision are largely neglected in clinical trials. In this presentation we will discuss changes in contrast and color vision associated with a variety of clinical disease states starting at the front of the eye and moving to the back.
Clinical Benefits of Diagnostic Color Vision Testing
1 in 5 may have a color vision deficiency. Contemporary eye care includes qualitative and quantitative assessment of this important measure of visual function.
Acquired color deficiencies are commonly S-cone (blue-yellow) type, but may also affect L- and M-cones.
Acquired deficiencies are typically gender neutral and become more common with age, yet may affect up to 15%* of the general population.
This important but often overlooked clinical sign may be caused by retinal, macular, optic nerve, trauma or neurological disorders, in addition to cataracts and high-risk meds, as well as hundreds of common drugs and substances**.
Testing for acquired color vision deficiencies may be one of the most
underutilized measures of functional vision. Commonly used color vision tests historically (such as printed pseudo-isochromatic, “Ishihara plates”, designed more than a century ago), may only test L and M-cone deficiencies, completely missing all S-cone (blue) deficiencies as well as being not quantitative. Genetic color vision deficiencies, most commonly affect males as a sex-linked trait and most commonly affect the L or M-cones.
After using Konan's ColorDx CCT HD product in the clinic, I am painfully aware of the severe limitations and deficiencies of the legacy tests.
Time to pile all of the old pseudoisochromatic tests, and color testing books, along with the lanterns and 15-color chips into a big rubbish pile and set them on fire.
It is time for the professions to embrace a serious upgrade.
Paul A. Harris, OD
Professor, Southern College of Optometry
High-precision color diagnostics require high-precision calibration for highest sensitivity.
ColorDx CCT HD devices are individually, precision calibrated at manufacturing prior to customer shipment.
Konan’s proprietary deep, synchronous calibration provides a high-precision baseline from which periodic verifications / calibrations are based to account for typical monitor color changes over time. CCT HD includes a USB colorimeter for routine calibrations, typically taking only about a minute.
Regulatory Compliance Around the World
ColorDx CCT HD is the world’s first cone-isolation, contrast sensitivity test to be FDA listed and CE marked. CCT HD is available in Canada, listed with TGA and in Japan, and applied for in Korea. Language localized instructions available in many countries.
ColorDx qualifies for CPT Code 92283 in the USA.
In the future, ECPs will move beyond testing only black and white visual sharpness and treat patients routinely to maintain their quality of color vision experience.
I use ColorDx CCT HD to assess and counsel patients with reduced contrast sensitivity as well as track progression.
Andrew Browne, MD, PhD
University of California, Irvine
Gavin Herbert Eye Institute
Department of Ophthalmology